Abstract
BAG-1 is a Bci-2-binding protein which functions in protection from apoptotic cell death. Here we provide evidence for interleukin-2 (IL-2)-mediated upregulation of BAG-1 expression. In hematopoietic cell line BAF-B03 F7 cells, gene transfer mediated expression of the IL-2R beta c chain is sufficient to confer proliferation and cell survival responses to IL-2. In these IL-2R beta c-expressing cells, BAG-1 mRNA was dramatically induced by IL-2. The IL-2-mediated induction of BAG-1 expression required the activation of tyrosine kinase(s) and was sensitive to rapamycin as the induction of bcl-2 expression was. Analysis of the transfectants which express mutant IL-2R beta c chains or mutant Janus family protein tyrosine kinase Jak3 lacking the kinase domain showed that the IL-2-mediated BAG-1 gene expression required the serinerich region within the IL-2R beta c chain, but Jak3 activation was dispensable. The signaling pathway for BAG-1 gene expression thus highly resembles that for bcl-2 gene expression, strongly suggesting that their induction shares the same signaling pathway. In addition, deletion of the serine-rich region led to loss of IL-2-mediated protection from apoptotic cell death. Taken together, these studies demonstrate that the serine-rich region of the IL-2R beta c chain mediates the coordinated expression of bcl-2 and BAG-1 genes, thereby contributing to suppression of apoptosis.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives
-
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
-
Animals
-
Apoptosis / drug effects
-
Apoptosis / genetics
-
Carrier Proteins / biosynthesis*
-
Carrier Proteins / genetics
-
Cell Line
-
DNA-Binding Proteins
-
Enzyme Inhibitors / pharmacology
-
Gene Expression Regulation / drug effects*
-
Genistein
-
Hematopoietic Stem Cells / drug effects*
-
Hematopoietic Stem Cells / metabolism
-
Humans
-
Interleukin-2 / pharmacology*
-
Isoflavones / pharmacology
-
Janus Kinase 3
-
Lymphocytes / drug effects
-
Lymphocytes / metabolism
-
Mice
-
Phosphorylation
-
Phytohemagglutinins / pharmacology
-
Polyenes / pharmacology
-
Protein Processing, Post-Translational
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Protein-Tyrosine Kinases / physiology
-
Proto-Oncogene Proteins c-bcl-2 / biosynthesis
-
Proto-Oncogene Proteins c-bcl-2 / genetics
-
RNA, Messenger / biosynthesis
-
RNA, Messenger / genetics
-
Receptors, Interleukin-2 / chemistry*
-
Receptors, Interleukin-2 / drug effects
-
Serine*
-
Signal Transduction / drug effects*
-
Sirolimus
-
Stimulation, Chemical
-
Tacrolimus / pharmacology
-
Transcription Factors
-
Transfection
Substances
-
BCL2-associated athanogene 1 protein
-
Carrier Proteins
-
DNA-Binding Proteins
-
Enzyme Inhibitors
-
Interleukin-2
-
Isoflavones
-
Phytohemagglutinins
-
Polyenes
-
Proto-Oncogene Proteins c-bcl-2
-
RNA, Messenger
-
Receptors, Interleukin-2
-
Transcription Factors
-
Serine
-
KN 62
-
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
-
Genistein
-
Protein-Tyrosine Kinases
-
JAK3 protein, human
-
Jak3 protein, mouse
-
Janus Kinase 3
-
Sirolimus
-
Tacrolimus